Acne 

Actinic Keratosis 

Aesthetics

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

COVID-19

Drug Watch

Dry Cracked Skin

Hidradentitis Suppurativa

Impetigo

Inflamed Skin

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Surgery

Vitiligo

Wound Care

News

Media

2 Minute Drill

Around the Practice

Between The Lines

Case Based Peer Perspective

DermView

Editorial Board News

Expert Interviews

Expert Perspectives

Frontline Forum

Inside the Clinic

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Viewpoints

Webinars

Conferences

Conference Coverage

Conference Listing

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Image IQ

Interactive Tools

Job Board

Polls

Editorial Advisory Board

Partnerships

Subscribe

Print Subscription

eNewsletter

Articles

Connect with us in-person and discover innovative practice pearls throughout the weekend.

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

 and joined the MJH Life Sciences team in June 2022. She attended Otterbein University in Westerville, Ohio, and earned a Bachelor of Arts degree in literary studies with minors in creative writing and film studies. Prior to health care news, Kaitlyn worked in industrial marketing. She enjoys cooking, reading, and tending to her house plants. 

This week’s collection of the latest dermatologic studies covers chronic pruritus of unknown origin, vaccinating dermatology providers for HPV, body dysmorphic disorder among Lebanese women, and a case report of a pleomorphic dermal sarcoma with metastasis to the lung. 

Journal Digest: September 26 

and joined the MJH Life Sciences team in February 2023. She attended Kent State University and earned a Bachelor of Science degree in journalism with minors in public relations and creative writing. She enjoys making and listening to music, reading, and spending time with her cats, Astrid and Marceline.

Sachin Shridharani, MD, discusses the results of a recent Allergan Aesthetics study exploring the efficacy of onabotulinumtoxinA in treating platysma prominence.

Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence

Ruth Ann Vleugels, MD, and Christopher Bunick, MD, agreed that the long-term safety data for JAK inhibitors makes them preferable to systemic steroids.

Medicare process demands dialogue

5 Ways to Negotiate the Best Physician Employment Contract

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

Disclosing Physician Health: What Is Required?

4 Key Tools to Protect Personal and Practice Assets

Expert Witness and Perjury

FDA Black Box Warning and Liability

5 Ways to Negotiate the Best Physician Employment Contract

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

Disclosing Physician Health: What Is Required?

4 Key Tools to Protect Personal and Practice Assets

Expert Witness and Perjury

FDA Black Box Warning and Liability

5 Ways to Negotiate the Best Physician Employment Contract

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

Disclosing Physician Health: What Is Required?

4 Key Tools to Protect Personal and Practice Assets

Expert Witness and Perjury

FDA Black Box Warning and Liability